GLOBAL CHOLERA VACCINES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global Cholera Vaccines Market, By Product Type (Vaxchora, Dukoral, ShanChol, Euvichol-Plus/Euvichol, Others), By Vaccine Type (Killed Whole-cell and Recombinant Cholera Toxin B Vaccine, Killed Whole-cell Only Vaccines, Live Attenuated Oral Cholera, Vaccine), By Patient Type (Pediatric, Adults), By Distribution Channel (Public, Private), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Global Cholera Vaccines Market - Regional Insights

North America is expected to be the largest market for cholera vaccines during the forecast period, accounting for over 37.1% of the market share in 2023. North America is anticipated to dominate the global cholera vaccines market during the forecast period due to strong public healthcare support and high awareness levels about cholera vaccination in the region.
Europe market is expected to be the second-largest market for cholera vaccines market accounting for over 20.6% of the market share in 2024. Europe is likely to witness the fastest gains and emerge as the most lucrative region towards the latter half of the forecast period. This can be attributed to increasing adoption of inorganic growth strategies by key market players.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa